Correlation Between Nanobiotix and Medesis Pharma

Can any of the company-specific risk be diversified away by investing in both Nanobiotix and Medesis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanobiotix and Medesis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nanobiotix SA and Medesis Pharma SA, you can compare the effects of market volatilities on Nanobiotix and Medesis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanobiotix with a short position of Medesis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanobiotix and Medesis Pharma.

Diversification Opportunities for Nanobiotix and Medesis Pharma

0.52

Correlation Coefficient

Nanobiotix  Medesis Pharma

Very weak diversification

The 3 months correlation between Nanobiotix and Medesis is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Nanobiotix SA and Medesis Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medesis Pharma SA and Nanobiotix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanobiotix SA are associated (or correlated) with Medesis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medesis Pharma SA has no effect on the direction of Nanobiotix i.e., Nanobiotix and Medesis Pharma go up and down completely randomly.

Pair Corralation between Nanobiotix and Medesis Pharma

Assuming the 90 days trading horizon Nanobiotix SA is expected to generate 1.21 times more return on investment than Medesis Pharma. However, Nanobiotix is 1.21 times more volatile than Medesis Pharma SA. It trades about 0.12 of its potential returns per unit of risk. Medesis Pharma SA is currently generating about 0.11 per unit of risk. If you would invest  279.00  in Nanobiotix SA on October 5, 2024 and sell it today you would earn a total of  22.00  from holding Nanobiotix SA or generate 7.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nanobiotix SA  vs.  Medesis Pharma SA

Nanobiotix SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nanobiotix SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Medesis Pharma SA

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Medesis Pharma SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Medesis Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Nanobiotix and Medesis Pharma

The main advantage of trading using opposite Nanobiotix and Medesis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanobiotix position performs unexpectedly, Medesis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medesis Pharma will offset losses from the drop in Medesis Pharma's long position.

The idea behind Nanobiotix SA and Medesis Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.